Literature DB >> 25948353

IgA nephropathy and psoriatic arthritis that improved with steroid pulse therapy and mizoribine in combination with treatment for chronic tonsillitis and epipharyngitis.

Tomohiro Kaneko1, Akiko Mii, Megumi Fukui, Kiyotaka Nagahama, Akira Shimizu, Shuichi Tsuruoka.   

Abstract

A 65-year-old man was admitted to our hospital with edema and renal dysfunction. He had received a diagnosis of psoriatic arthritis at 50 years of age. As a renal biopsy showed IgA nephropathy (IgAN), bilateral tonsillectomy was performed, and one course of steroid pulse therapy with an oral steroid and mizoribine were subsequently administered. The patient's proteinuria gradually reduced in association with an improvement in the renal function. In addition, the rash and arthralgia were ameliorated. In this case, adding treatment for chronic epipharyngitis accelerated the curative effects, and focal infection therapy consisting of immunosuppressive drugs was effective for both IgAN and psoriatic arthritis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25948353     DOI: 10.2169/internalmedicine.54.3510

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA).

Authors:  Osamu Hotta; Ayaki Tanaka; Akira Torigoe; Kazuaki Imai; Norio Ieiri
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  Epipharyngeal Abrasive Therapy Down-regulates the Expression of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2.

Authors:  Kensuke Nishi; Shohei Yoshimoto; Soichiro Nishi; Toshiyuki Tsunoda; Jun Ohno; Michinobu Yoshimura; Kenji Hiromatsu; Takafumi Yamano
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 3.  Toll-Like Receptor as a Potential Biomarker in Renal Diseases.

Authors:  Sebastian Mertowski; Paulina Lipa; Izabela Morawska; Paulina Niedźwiedzka-Rystwej; Dominika Bębnowska; Rafał Hrynkiewicz; Ewelina Grywalska; Jacek Roliński; Wojciech Załuska
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.